A two-year clinical trial that compared three drugs for diabetic macular edema (DME) found that gains in vision were greater for participants receiving the drug Eylea (aflibercept) than for those…
Category: News
Squint a symptom in third of retinoblastoma cases in the UK
A third of babies and children in the UK diagnosed with childhood eye cancer have a squint as a symptom, according to new figures1.
108 million people have correctable vision impairment, global study estimates
Uncorrected refractive error (URE)–nearsightedness, farsightedness, and other focusing problems correctable by prescription lenses–is responsible for moderate to severe vision impairment in 101…
Zika in Early Pregnancy May Be More Dire, CDC Suggests
The CDC found more fetal brain abnormalties than it expected. Perhaps not surprisingly, the agency cautioned pregnant women today not to attend the summer Olympics in Brazil, epicenter of the Zika outbreak. Medscape Medical News
An Airbag Deploys, Leaving Vision Blurry and Distorted
A 53-year-old man’s lingering ocular injuries from a car accident 3 weeks earlier do not respond to topical treatments. Will gonioscopy clear up the diagnosis? Medscape Ophthalmology
Atorvastatin: A Drusen Disintegrator?
Can treatment with a high-dose statin for age-related macular degeneration resolve drusen and improve visual acuity? Medscape Optometry
Healthcare Takes Center Stage at Republican Debate
(MedPage Today) — Candidates argue over whose plan is best
Second Sight Mourns Loss and Celebrates Legacy of Founder Alfred E. Mann
SYLMAR, Calif.–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, today mourns the passing of Founder Alfred E. Mann. “We are all deeply saddened by the loss of our founder, mentor and friend, Al Mann, a pioneering leader whose contributions and vision profoundly impacted the lives of so many and whose legacy will impact m
Candidates’ Drug-Price Plans may Miss the Mark
(MedPage Today) — Tradeoffs must be made, experts say
Patient Awareness of Emergency Eye Problems Is Low
Serious eye problems like retinal detachment can come on suddenly and require immediate care, but few people are aware of these conditions, much less how they’re treated, a small U.S. study finds. Reuters Health Information
Ranibizumab for the Treatment of Wet AMD
Ranibizumab for wet AMD has shown success in clinical trials, but are those same results achieved in real-world clinical practice? Eye
Unilateral Glaucoma?
A 44-year-old man presents with blurred vision in one eye that is worse in the morning. What is the cause of his visual complaint? Medscape Optometry
Research offers hope for better treatments for retinal degenerative diseases
Two studies advance scientific understanding of a safe method for producing retinal pigment epithelial-like cells for transplantation and an effective way to repair the damaged substrate beneath…
Genomic sequencing reveals link between STIs and leading cause of infectious blindness
Chlamydia trachomatis can exchange genes between infection sites.For the first time, genome sequencing has been carried out on Chlamydia trachomatis (C.
Results for concussion sideline vision tests may vary when English is a second language
Popular sideline vision tests used to help detect immediate signs of concussion may present challenges in the interpretation of results for athletes who speak English as a second language (ESL).
Genomic sequencing reveals link between stis and leading cause of infectious blindness
For the first time, genome sequencing has been carried out on Chlamydia trachomatis (C.
How Should Physicians Respond to Racist Patients?
A framework for assessing and responding to a patient’s request on the basis of race or ethnicity can help clinicians navigate a painful, yet often inevitable, experience. Medscape Medical News
AMA Members: Focus on Regulations, Not Legislation
(MedPage Today) — Congress won’t pass many bills in a presidential election year
Cataracts Pipeline – Global API Manufacturers, Marketed and Phase III Drugs Landscape 2016 – Research and Markets
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/rnz2xt/cataractglobal) has announced the addition of the “Cataract-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016” report to their offerin…
Drug Discovery in Ophthalmology
This review discusses the evolution of ophthalmic drug development, the present challenges, and what the future holds. BMC Ophthalmology